October 17, 2023
Company Description: Inimmune is harnessing the human immune system to create next generation immunotherapeutics for the treatment of allergy, infectious disease, autoimmunity, opioid addiction and cancer.
CEO/Top Company Official
Alan F. Joslyn, Ph.D.
Lead Product in Development
INI-2004: Allergy INI-4001: immuno-oncology
Development Phase of Primary Product
Number Of Unlicensed Products
two (INI-2004 & INI-4001)